IMS-III and SYNTHESIS Expansion trials of endovascular therapy in acute ischemic stroke: how can we improve?

Stroke. 2013 Nov;44(11):3272-4. doi: 10.1161/STROKEAHA.113.002380. Epub 2013 Oct 10.

Authors

Raul G Nogueira¹, Rishi Gupta, Antoni Dávalos

Affiliation

¹ From the Departments of Neurology, Neurosurgery, and Radiology, Marcus Stroke and Neuroscience Center, Grady Memorial Hospital, Emory University School of Medicine, Atlanta, GA (R.G.N., R.G.); and Department of Neurosciences, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Barcelona, Spain (A.D.).

PMID: 24114453
DOI: 10.1161/STROKEAHA.113.002380

No abstract available

Keywords: clinical trials; stroke; thrombectomy; tissue-type plasminogen activator.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Angiography / methods
Clinical Trials as Topic
Endovascular Procedures / methods*
Evidence-Based Medicine
Humans
Infusions, Intravenous / methods
Mechanical Thrombolysis / methods
Patient Selection
Research Design
Stroke / therapy*
Thrombolytic Therapy / methods*
Tissue Plasminogen Activator / therapeutic use*
Treatment Outcome

Substances

Tissue Plasminogen Activator